This study wasdesignedto determine whetherpatients withperipheralvasculardisease (PVD) P ERIPHERAL vasculardisease(PVD) is a relatively common, debilitating diseasein the elderlypopulation(1-4). It is caused by the atheroscleroticblockage of arteriesin the lower abdomen and legs.The blockageusuallyoccurs at one or more points along the lower aortic, iliac, femoral, or popliteal arteries, and leads to decreased blood flow distal to the point where it occurs. One of the classic symptomsof PVD is intermittentclaudication. During walking, the vascularsystem of the lower extremities is unable to meet the increase in metabolic demand. This results in what is called ischemic leg pain of an intensity that causes the patient to stop walking. Restingallowsthe oxygendebt to be cleared,which then reduces or eliminates the pain. When the patient resumes walking,the ischemicpain returns at much the same walking distance as before.This cycle leads to a reduced functionalcapacity in persons withPVD, as they are unableto walk as far or as fast as healthy individuals within the same age range (5). Despite the direct impact of PVD on walking distance, few studieshave examined PVD patients for abnormalities in the gait pattern during walking. In addition,it has been speculatedthat changes in walking technique are one of the factors that might account for exercise training-induced reductions in claudication pain (6).
P
ERIPHERAL vasculardisease(PVD) is a relatively common, debilitating diseasein the elderlypopulation (1) (2) (3) (4) . It is caused by the atheroscleroticblockage of arteriesin the lower abdomen and legs.The blockageusuallyoccurs at one or more points along the lower aortic, iliac, femoral, or popliteal arteries, and leads to decreased blood flow distal to the point where it occurs. One of the classic symptomsof PVD is intermittentclaudication. During walking, the vascularsystem of the lower extremities is unable to meet the increase in metabolic demand. This results in what is called ischemic leg pain of an intensity that causes the patient to stop walking. Restingallowsthe oxygendebt to be cleared,which then reduces or eliminates the pain. When the patient resumes walking,the ischemicpain returns at much the same walking distance as before.This cycle leads to a reduced functionalcapacity in persons withPVD, as they are unableto walk as far or as fast as healthy individuals within the same age range (5) . Despite the direct impact of PVD on walking distance, few studieshave examined PVD patients for abnormalities in the gait pattern during walking. In addition,it has been speculatedthat changes in walking technique are one of the factors that might account for exercise training-induced reductions in claudication pain (6) .
One studyexaminedgaitin a smallgroupof patients with PVD (7) . This study had individuals with PVD walk over force plates capable of measuring force vectors in three dimensions. There were no differences betweensubjectswith and withoutPVD. This study also reported no change in gait variables of PVD subjects who performed toe-raisesto induce claudication,although it was not clear if claudication persistedduring the actualgait testingperiod.It was also not clearwhetherwalkingspeedwas controlled. A study using a rat model demonstratedthat lefthind limb ischemia producedby arterial ablationsignificantly alteredgait.The animals showedan asymmetrical gait duringspontaneous walking in a 1-m long chamber, which was consistent with reduced weightbearing in the affected limb (8) . The limitation of this studywas that it used a young quadruped animal as a model for human PVD. Based on theseresults, we felt thatan additional studywas needed.
The purpose of this study was to determine if persons with PVD who demonstrated intermittent claudication had quantifiable disease-associated gait alterations. We measured self-selected walking speed and various indicators of gait asymmetry in subjects with PVD in the presence and absence of claudicationpain. The resultswere comparedto age-matched subjects withoutPVD.
METHODS

Study Population
All study participants were members of a regular medically supervised exercise program and exercised approximately three times per week for at least 20 minutes per session. All subjects were familiar with walking on a motorized treadmill, although none of the subjects had previously had a gait analysis performed. All subjects were free of leg pain or weakness not related to PVD. The PVD group was comprised of patients with documented mild to moderate PVD who reported ischemic pain in one or both legs during treadmill walking. Age-matched control subjects had no medical history of PVD and did not report ischemic pain on walking. This study was approved by the Committee for the Protection of Human Subjects, Medical College of Pennsylvania and Hahnemann University, and all subjects gave informed consent before participating.
Measurements
The GaitMatII system was used to measure both temporaland spatialvariables of gait (9) . The systemconsistedof a mat containing foot-activated switches linkedto a computer. The recording surface was 3.87 m long and 0.75 m wide, and 0.03 m above the ground. Twoplywoodplatforms, each 1.5m long,and0.75 m wide, and 0.03 m thick, were connected to both ends of the pathway to provide an extended walking surface. The recording pathway was dividedinto 40 rows and 256 columnsof pressure switches that formed a two-dimensional grid (l em X 1 cm). When the subjects walked across the recording surface, the timing of the opening and closing of the switches with each footfall was recorded. The switches were scanned every30 milliseconds (ms) to detect closures and openings. The spatial accuracy of the GaitMat II was ± 15 mm. A computer software program was usedto calculate thefollowing temporal-distance variables: walking speed, step length, step time, swing time, stance time, and doublesupporttime ( Figure 1 ).All measurements, exceptspeed, weretakenseparately for the leftandrightlegs.
Participants were asked to walk in a straight line for 10m, with the gait mat located in the middleof this distance. Subjects walked across the 10-m course four to six times. Subjects were instructedto walk at their own self-selected comfortable speed. Consistentverbalinstructionswereprovidedto all subjectsduring the walkingmeasurements.
Gaitmeasurements weretaken twice foreachsubject, first while thesubject wasrested andfeltno ischemic pain, andthenafter walkingon a treadmill. Participants withPVDwalked on thetreadmill at a speedandinclinethat was designed to resultin ischemicpainin one or bothlegswithin 10minutes. The speedsand inclineswere based on priorknowledge of thesubjects. PVDsubjects wereasked to walkuntiltheyexperienced moderate intermittent claudication, whichwasdefined as pain levels thatreached between5 and 8 out of 10.A descriptive pain scale of 1-10 (l0 being the worst) was used. Painlevels wererecorded forbothlegs. PVDparticipants then immediately repeated the walking teston theGaitMat II system. To ensurethat no delayoccurredbetweentreadmill walkingand the gaitmeasurements, the treadmillwaspositioned at the startof the 10-mwalking path.At the conclusion of the secondgaittest,subjectswereasked to giveanother painrating to determine ifclaudication painpersisted duringthe secondgaitmeasurements. Control subjects followed a similarprotocol. Priorto the secondgaitmeasurement, control subjects walked onthetreadmill for 10minutes at a speedandincline prescribed as partof theirnormalexercise program. Control subjects alsorepeated thegaitmeasurements immediately after completing thetreadmill walking. Gait asymmetry was assessed by calculating the ratios of left/right (LflRt) step length, LflRt step time, and LflRt stance/swing time. Thiswasdonefor all subjects andfor the seven subjects whoreported greaterclaudication painin therightleg.
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To assess of the reliability of the subjectsto selecta comfortable walking speed, a subset of subjects (six PVD and six controls) were tested on a second occasion. In all but one case, the time between the two testing days was 2-7 days. In one subject the time intervalwas 3 weeks.
Data Analysis
Age, height, weight,and leg length were collected for all subjects. Leg length was determinedby subtractionfrom measurementsof standingheightand sittingheight (9) .All gaitdata were storedon computerdisksand analyzedby an investigator experienced in Gait Mat measurements (10) who was blinded to the identification of the data. Data were firstcleanedby eliminating any artifacts and any half steps at the beginning and end of the recording surface. Then the data were averaged for the four to six timesacrossthe recording surface. After this the data were transferred to a database spreadsheet and the summary data sortedand identified by subjectand test. Statisticalanalysiswas performed usingcomputer software packages, Statview(AbacusConcepts, Inc., Berkeley,CA) for determinationof statisticaldifferences, and Samplepower(SPSS,Inc., Chicago, IL) for power calculations. Potential differences were analyzed using independent t tests to compare pretreadmill values between the PVD and control groups. To correct for multiple measurements, we used a p value of .01 as our indicatorof statisticalsignificance. Potential differences betweenPVD and controlgroupsin theirresponse to treadmillwalking were determinedusing independentt tests of the difference scores (post-minus pretreadmillmeasurements). The abilityof the subjects to reproducethe self-selected walking speedwas determined usingPearson correlations.
REsULTS
Physical Attributes
Nine male subjects with PVD and 10 male control subjects were tested.There wereno significant differences in subjectage or sizebetweengroups (Table 1) .Fiveof the subjects in thisstudy werepart of a cardiac rehabilitation programas theyhad suffered recent cardiac incidents (three were in the PVD group and two were in the control group). However, no systematicdifferences were noted between these subjects and the other subjectsin the study. All subjects completed the testing without incident.
First Test(Rested)
There were no significant differencesin any of the gait measures between PVD and control subjects prior to treadmillwalking exercise (Table 2) . Neither PVD or control groups showed any systematic asymmetries in gait between the left and right legs. In the PVD group, analyzing gait asymmetryby the leg with greatest reported claudication pain still did not result in any measurable asymmetries.
After Exercise
PVD subjectswalkedon the treadmillat 2.5 ± 0.6 mph at 2.4 ± 3.3 % gradefor 421 ± 112seconds (s) (range 176-555s).After exercise, the PVD subjects reportedclaudication pain of 5-8 out of a scale of 0=-10 (10 = maximalpain). Three PVD subjectsre- Table 2 .
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GaitVariables for the PVD and ControlGroups During the First TestPrior to TreadmillWalkingand Claudication Pain
Notes: PVD subjects all reported claudication pain whereas the control subjects did not. Values are means ± SD. ported pain only in the right leg, four reported pain in both legs but more intense in the right leg, and two reported pain equally in both legs. In eight subjects the pain persisted at the same or greater levels throughout the gait testing. In one subject claudication pain subsided rapidly after stopping treadmill walking and was gone or nearly gone by the time he finished the gait mat measurements. The control group walked at 3.2 ± 0.5 mph at 1.4 ± 1.9 % grade for 600 seconds. None of the subjects in the control group reported claudication pain or any other problem at any time during the study.
The PVD group walked slower on the second test after walking on the treadmill, whereas the subjects in the control group walked faster (Table 3 ). The PVD group showed some significant alterations in gait after treadmill exercise compared to control subjects (Figure 2 ). In addition to walking speed, the PVD group had shorter step lengths, slower step times, and longer stance times compared to control subjects. Double-support times showed a trend towards signficance, with double-support time calculated from the left leg having a p value below .01, and the double-support time for the right leg had ap value above .01.
No differences were found between gait variables for the left and right legs in either the PVD or control groups. This included comparing the left to right legs in all subjects, as well as left to right legs in the seven PVD subjects who reported greater claudication pain in the right leg. The largest difference found was 4% in the ratio of left to right stance to swing time ratio 
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Reproducibility
The ability to reproduce the self-selected walking speed was tested on a subset of six PVD and six control subjects. Comparisons were made to determine pretreadmill and posttreadmill reliability for each group. For walking speed, the test-retest Pearson correlations were .76 for the PVD pretest, .93 for PVD postexercise test, .94 for control pretest, and .95 for control postexercise test. There was no difference in walking speed between the first and second tests in either the PVD or control groups on either the pre-or posttreadmill tests (p values> .25). The other gait variables showed similar test-retest results, except the correlation coefficents were slightly lower (.52 to .75). 
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DISCUSSION
The aim of this study was to identifywhether individuals with PVD have gait abnormalities. Significant decreases in walking speed and step length and increases in step time were found in PVD subjects whenclaudication pain waspresent. The presenceof gaitabnormalities was alsoreportedin a studythatused a rat model of PVD (8) . In this model, PVD was induced by surgical ligation of the leftcommoniliacartery. The rats wereallowedto walk spontaneouslyand speed and foot fall patterns measured. In contrastto our study which found reduced walking speed with symmetrical gait patterns, the rats with ligated arteries maintainedtheir spontaneous walkingspeed,but had significantly slowerstanceand footfloor contact times in the ischemic leg. The different study outcomes could be due to differencesbetween experimentalmodels: comparing humans (bipeds) to rats (quadripeds), self-selected walking speedto spontaneous walking speed, and moderatevascular occlusionto arterial ligation. A studyon humans with PVD did not reportalteredgaitpatternswithclaudication pain (7) . However, the experimental details presented in this paper were vague as to how the walking speed was set and whetherclaudicationpain occurred during the post toe-raiseexercisemeasurements.Thus it is not easyto comparethis studyto ours.
In our studywe did not findevidencethat PVD patientsfavored the leg withthe most severeclaudication pain.However, it is possible that small differences in gait occurredthat we were not able to detect withour presentsample size.Our findings are in agreement with a previoushuman study of gait whichfound no asymmetries in gait in subjects with PVD (7). This previous study measured groundreaction forces, stepfrequency, and stancedurationin seven subjects withPVD and 11controls. As mentioned previously, asymmetrical gaitpatterns werereported in a ratmodelofPVD (8) .
Our results suggest that PVD subjects do not show major gait adaptations while free of claudication pain. This suggests that although the onset of the disease is gradual and most patients have had the disease for many years, normal gait patterns are retained. The primary adaptation to the onset of claudication pain seems to be to slow down, take smaller steps, and maintain gait symmetry. Interestingly,when two of the subjects with PVD were encouraged to walk faster than their preferred walking speed, they developed a noticeable gait asymmetry along with their claudication symptoms (unpublished observations). This suggests that gait asymmetries are a possible adaptation to claudication pain, but not when the PVD subjects are allowed to select their own walking speed.
One of the primary reasons for examining gait in PVD subjects is that changes in gait patterns may have a major impact on walking efficiency. A better understandingof how PVD subjects walk might result in the design of therapies that could alter and thus improve walking distances in these patients. Exercise training has been shown to produce improvements in walking distance of up to 100% in PVD subjects (11) . Whereas the mechanism for this improvement is unclear, previous studies have suggested that total limb blood flow does not improve, although there maybe a redistribution of blood flow to the lower limb to active muscles from inactive tissues (4, 6, 12) . One of the possible mechanisms for improvement in walking distance would be alterations in gait (6) . This could occur by making walking more efficent in terms of using muscles with adequate blood flow while not using muscles with reduced blood flow.
Our study does have a number of limitations. The sample size was small, and it mighthave been easierto identify asymmetries in gait if a larger number of subjects were studied, particularlysubjects with pronounced differences in claudication pain between their legs. However, a number of subjects in this study did have pronounced differencesbetween legs, and no hint of a consistent effectwas noticed in them. Future studies will be needed to determine the impact of smallchangesin gait asymmetry. Another potentiallimitation was the choice of self-selected walking speed. Askingsubjectsto walkat set speeds,includingspeedsabovetheir preferred walking speed, might have resulted in more gait asymmetries. All subjectsin this studywere members of a regularexerciseprogram,including allof the PVD subjects. As regularexercisers make up lessthan 20% of the olderpopulation, thisrepresents a subsetof subjects thatmay be different than the generalpopulation. Familiarity with treadmill walking might havemade thispart of the studyeasierthan it wouldhavebeen in naivesubjects.
In summary, our resultsshowedthat PVD subjects showno gait alterations while symptom-free, but do altertheirgait whenexperiencingclaudication pain.The primaryalteration seemsto be reduction in preferred walking speed, with a preservation in walking symmetry, evenifone leghas moreclaudication pain thatthe other.
